XML 25 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income/(Loss)
Retained Earnings
Equity, beginning balance (in shares) at Dec. 31, 2021   137,498      
Equity, beginning balance at Dec. 31, 2021 $ 196,953 $ 138 $ 256,347 $ (620) $ (58,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 10,377   10,377    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)   616      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 4,445 $ 0 4,445    
Repurchase of common stock (shares)   (433)      
Repurchase of common stock 0 $ 0 0    
Other comprehensive income (loss) (1,397)     (1,397)  
Net income 82,793       82,793
Equity, ending balance (in shares) at Jun. 30, 2022   137,681      
Equity, ending balance at Jun. 30, 2022 293,171 $ 138 271,169 (2,017) 23,881
Equity, beginning balance (in shares) at Mar. 31, 2022   137,888      
Equity, beginning balance at Mar. 31, 2022 260,256 $ 138 261,713 (2,791) 1,196
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 5,635   5,635    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)   226      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 3,821 $ 0 3,821    
Repurchase of common stock (shares)   (433)      
Repurchase of common stock 0 $ 0 0    
Other comprehensive income (loss) 774     774  
Net income 22,685       22,685
Equity, ending balance (in shares) at Jun. 30, 2022   137,681      
Equity, ending balance at Jun. 30, 2022 293,171 $ 138 271,169 (2,017) 23,881
Equity, beginning balance (in shares) at Dec. 31, 2022   135,154      
Equity, beginning balance at Dec. 31, 2022 169,798 $ 135 27,368 (922) 143,217
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 17,588   17,588    
Issuance of common stock for the induced conversion related to convertible notes (in shares)   289      
Issuance of common stock for the induced conversion related to convertible notes (126) $ 0 (126)    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)   578      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 1,398 $ 1 1,397    
Repurchase of common stock (shares)   (4,165)      
Repurchase of common stock (151,301) $ (4) (34,159)   (117,138)
Other comprehensive income (loss) (693)     (693)  
Net income 114,369       114,369
Equity, ending balance (in shares) at Jun. 30, 2023   131,856      
Equity, ending balance at Jun. 30, 2023 151,033 $ 132 12,068 (1,615) 140,448
Equity, beginning balance (in shares) at Mar. 31, 2023   131,662      
Equity, beginning balance at Mar. 31, 2023 65,850 $ 132 0 24 65,694
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 9,622   9,622    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)   194      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 2,446 $ 0 2,446    
Other comprehensive income (loss) (1,639)     (1,639)  
Net income 74,754       74,754
Equity, ending balance (in shares) at Jun. 30, 2023   131,856      
Equity, ending balance at Jun. 30, 2023 $ 151,033 $ 132 $ 12,068 $ (1,615) $ 140,448